Elections

ARMS Elections 2018

Candidates for the 2018 Elections are provided in alpha order below:


Ballot for the role of ARMS Committee Member:

 

Please be advised that only voting members of ARMS are entitled to cast a vote for this election round.  Each voting member will receive a link to an online ballot on the 24th of August.  Voting closes 5 PM AEST on the 6th of September.

 


 

Dr Johanna Barclay is the Research Development Manager, leading the Strategic Development Team for Mater Research in Brisbane. Under her stewardship, this team oversees a diverse and complex portfolio including all aspects of funding (identification, application support and review, pre- and post-award administration), research education, research engagement (biomedical, clinical, industry, philanthropy and government), research communications, research metrics and impact, as well as biostatistical and database support.

Johanna’s success in these activities, exemplified by her rapid advancement within the organisation, is underpinned by her experience as a researcher.  Johanna achieved her PhD from The University of Queensland (UQ) in 2007, and went on to undertake successful postdoctoral positions at the Institute for Molecular Bioscience (UQ), the Max Planck Institute for Biophysical Chemistry (Germany), the Faculty of Medicine (UQ), and Mater Research.  Her research spans both biomedical and clinical fields, and has given her broad understanding of the Australian research landscape as well as an appreciation of the international landscape.  Johanna remains an active researcher and is involved in studies which span the entire translational pipeline from discovery through to implementation.

Johanna has expertise with identifying and developing new strategies to increase and diversify research support, and is passionate about forming partnerships through effective networking.  She has a keen appreciation of the multitude of models under which research is performed in Australia, and is driven to identify creative initiatives which leverage existing research strengths to achieve tangible outcomes. Her skills and knowledge are widely acknowledged outside of Mater Research, and she is a valued member of management and governance committees within Mater Health and Mater Foundation.

Johanna-Barclay-1.jpg


 

Photo Stutdhbury.jpg

Dr Tamantha Stutchbury is Program Director of the Global Challenges Program at the University of Wollongong (UOW). Dr Stutchbury manages the Program's operations and is responsible for managing the growth of its internal and external networks. She is passionate about profiling the impact of the program and its hundreds of projects locally and globally, and has played a significant role in supporting the academic and transformational outcomes of the research. Dr Stutchbury is heavily involved in the research strategy and trajectory of the Global Challenges program and each of the projects it supports. She is a strong advocate for gender equity, STEM engagement and research engagement. She was instrumental in writing a White Paper on challenge-led interdisciplinary research presenting the challenges and achievements of the research program since its launch in 2013.

Dr Stutchbury has extensive experience launching and implementing programs in the Higher Education sector. Prior to joining the Global Challenges leadership team, she was a Senior Innovation Development Manager leading innovative projects to develop UOW's engagement with industry and the wider community. She was also the inaugural General Manager of a proof of concept incubator for UOW iAccelerate and has expertise in IP management and commercialisation of University-led research.

Dr Stutchbury holds a BMedChem (Hons), a PhD in Biochemistry and a Master of Management (Dist). Her research experience spans over a decade in the area of pre-clinical assessment of novel cancer therapeutics, and she has authored a number of peer reviewed publications. The pre-clinical success of technology stemming from this research is currently in human clinical trials (fivepHusion) and has resulted in a number of Patents granted in the USA, Europe, China.